Utilizing α-particles, Czernin et al. explored the synergistic effects of [225Ac]Ac-PSMA-617 and PD-1 blockade in a mouse model of PCa, finding that these treatments significantly enhanced therapeutic outcomes. The gene discussed is FOLH1; the disease is posterior cortical atrophy.